This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Morphosys Ag, Morphosys Gmbh. Active years: 2003-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Planegg, DE (2003)
- München, DE (2015)
- Munich, DE (2020)
Company Filing History:
Years Active: 2003-2026
Title: Christian Frisch: Innovator in Antibody Technology
Introduction
Christian Frisch is a notable inventor based in Munich, Germany. He has made significant contributions to the field of antibody technology, holding a total of 4 patents. His work focuses on developing complex-specific antibodies and innovative screening strategies for identifying binders that target enzymatic antigens.
Latest Patents
Frisch's latest patents include groundbreaking inventions such as "Complex-specific antibodies and antibody fragments and its use." This invention provides antibodies and fragments that specifically detect the complex of a cognate antigen-binding moiety and its antigen. The antibodies disclosed do not bind to either the cognate antigen-binding moiety or the antigen alone, allowing for direct detection of antigen-bound antigen-binding moieties. Another significant patent is related to "Screening strategies for the identification of binders." This invention reveals novel strategies for identifying binders that target the active site of enzymatic antigens, specifically focusing on the NS2B-NS3 Proteinase of the West Nile Virus. The antigen-binding moieties developed have numerous therapeutic and diagnostic applications.
Career Highlights
Christian Frisch is currently associated with Morphosys AG, a leading biotechnology company. His work at Morphosys AG has positioned him as a key player in the development of innovative antibody technologies.
Collaborations
Frisch collaborates with esteemed colleagues such as Achim Knappik and Titus Kretzschmar, contributing to the advancement of research in antibody technology.
Conclusion
Christian Frisch's contributions to the field of antibody technology are noteworthy, with his innovative patents paving the way for advancements in therapeutic and diagnostic applications. His work continues to impact the scientific community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile